Is the price fair?
What ASH's price assumes
Ashland Inc. trades at 70.8× earnings against 28.3× for the median Specialty Chemicals name, more expensive than its own group.
70.8
Trailing P/E · Specialty Chemicals median 28.3 · 2.50× the median: the market pays up for this one
- Price / sales
- 0.00
Price / sales · as of 2026-Q1
- Free cash flow yield
- 8.0%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- −0.67%
Growth the price implies · The price pays for −0.67% free cash flow growth a year for a decade; the business has delivered +8.6% a year over the last three.
Details›
- Price / book2026-Q1
- 0.00
- EV / sales2026-Q1
- 0.57
- Basic Materials median P/E153 names
- 22.8
- Specialty Chemicals median P/E37 names
- 28.3
- Free cash flow, trailing twelve months
- $250M
- Market capitalisation
- $3.11B
- 3-year revenue growth
- −7.2%
- 3-year free cash flow growth
- +8.6%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $15.63 |
| Its own P/E history, median | $23.75 |
| Its own P/E history, upper quartile | $29.96 |
| 52-week range | $46.46 – $76.45 |
| Today | $74.32 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #6 of 36 by Smart Score